RxDoctor Payments Data

Stephen Shiller

Interventional Pain Medicine · Tucson, AZNPI 1316252315

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 76.2% of it on its own, with 12 other manufacturers making up the rest. That places this record below the midpoint for interventional pain medicine clinicians in AZ, where the typical reported total is $8,993.

$3,376in general payments, 2019–2025

Across 244 payments — averaging $13.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Radius Health, Inc.$163
  • SPR Therapeutics, Inc$137
  • MDD US Operations, LLC$131
  • Pacira Therapeutics, Inc.$122
  • Biodelivery Sciences International, Inc.$75
  • plus $173 from 7 others

What the payments were for

  • Food & beverage$3,376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,376 in reported general payments places this provider in the 30th percentile of 64 interventional pain medicine providers in Arizona.

See all interventional pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$453,357
Medicare patients
600
Services billed
6,749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate98$52,215
Buprenorphine196$37,833
BelbucaBuprenorphine Hcl42$22,216
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen562$17,736
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen540$15,928
LyricaPregabalin20$14,216
Oxycodone Hcl698$12,055
OxycontinOxycodone Hcl29$11,528
Naloxone Hcl184$9,969
Morphine Sulfate ErMorphine Sulfate427$9,909
Gabapentin571$7,845
MovantikNaloxegol Oxalate17$7,831
Pregabalin267$6,199
Methocarbamol179$4,504
ButransBuprenorphine13$4,456

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →